Interferon-α Revisited: Individualized Treatment Management Eased the Selective Pressure of Tyrosine Kinase Inhibitors on BCR-ABL1 Mutations Resulting in a Molecular Response in High-Risk CML Patients

Bone marrow transplantation or ponatinib treatment are currently recommended strategies for management of patients with chronic myeloid leukemia (CML) harboring the T315I mutation and compound or polyclonal mutations. However, in some individual cases, these treatment scenarios cannot be applied. We...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:PLoS One
Autores principales: Polivkova, Vaclava, Rohon, Peter, Klamova, Hana, Cerna, Olga, Divoka, Martina, Curik, Nikola, Zach, Jan, Novak, Martin, Marinov, Iuri, Soverini, Simona, Faber, Edgar, Machova Polakova, Katerina
Formato: Artigo
Lenguaje:Inglês
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4877000/
https://ncbi.nlm.nih.gov/pubmed/27214026
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0155959
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares